Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.

NCT03541330 | Terminated

• 2 other identifiers: 2016_832016-A02091-50
• Study Type: interventional
• Target: 7
• Locations: 1 country
• Sites: 1

Brief Summary

The primary objective is to evaluate the experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy at the Centre Hospitalier Régional et Universitaire of Lille

Conditions

Malignant Haemopathy

Keywords

Siblings; information; malignant haemopathy

Outcome Measures

Primary Outcomes (1)

• Level of satisfaction and characteristics of information received about the disease by healthy siblings of children with hematological malignancies

  Measure Qualitative Interviews by Grounded theory. The experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy. Assessment of the level of satisfaction with the information received. The information will be characterized according to three dimensions: the framework (by whom, with whom, where, when, how) and the content of the information

  1 year

Secondary Outcomes (3)

• Explore the representations of the disease in healthy siblings

  1 year

• Evaluate their information and support needs following the announcement of the disease

  1 year

• Identify the possible psychic and social consequences of the disease in these healthy subjects

  1 year

Study Arms (1)

siblings

OTHER

Brother or sister of a child has malignant haemopathy and follow-up in the pediatric hematology department

Other: semi-directive interview

Interventions

semi-directive interview OTHER

semi-structured interview conducted by a clinical psychologist

siblings

Eligibility Criteria

• Age: 6 Years - 12 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• Children from 6 to 12 years old
• Brother or sister of a child:
• O has malignant haemopathy O follow-up in the pediatric hematology department in Lille, O diagnosed from 6 weeks to 1 year before maintenance of the healthy subject included
• whose parents are able to understand and sign voluntarily informed consent
• Affiliated to a social security scheme
• Ability to understand and answer questions alone during the semi-structured interview

You may not qualify if:

• Child under 6 years or over 12 years
• Subject with a pathology that may interfere with the course of the study, according to the investigator's assessment
• Absence of the informed consent of one of the parents and / or the legal representative
• Refusal of participation of the subject

Sponsors & Collaborators

• University Hospital, Lille: lead

Study Sites (1)

Hôpital Jeanne de Flandres, CHU

Lille, France

Location

Study Officials

• Eva De Berranger, MD

  University Hospital, Lille

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 8, 2017
• First Posted: May 30, 2018
• Study Start: October 22, 2018
• Primary Completion: April 1, 2019
• Study Completion: April 1, 2019
• Last Updated: December 11, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)